Induced pluripotent stem cells (iPSCs) hold immense potential in disease modeling, drug
discovery and regenerative medicine. Despite advances in reprogramming methods …

Background & Aim Induced pluripotent stem cell (iPSC) research is rapidly moving towards
translational and clinical applications. These applications require robust and consistent …

The discovery of induced pluripotent stem cells (iPSCs) by Shinya Yamanaka in 2006 was
heralded as a major breakthrough of the decade in stem cell research. The ability to …

Induced pluripotent stem cells (iPSCs) paved the way for research fields including cell
therapy, drug screening, disease modeling and the mechanism of embryonic development …

The conversion of somatic cells into pluripotent cells is transforming the way diseases are
studied and treated. Owing to their ability to differentiate into any cell type in the body and …

Generation of induced pluripotent stem cells (iPSCs) has revolutionized the field of
regenerative medicine by providing researchers with a unique tool to derive disease-specific …

Differentiated cells can be reprogrammed into pluripotent stem cells, known as “induced
pluripotent stem cells”(iPSCs), through the overexpression of defined transcription factors …

Reprogramming adult somatic cells into induced pluripotent stem cells (iPSCs) through the
ectopic expression of reprogramming factors offers truly personalized cell-based therapy …

Stem cells are classified into embryonic stem cells and adult stem cells. An evolving
alternative to conventional stem cell therapies is induced pluripotent stem cells (iPSCs) …

The recent generation of induced pluripotent stem cells (iPSCs) from somatic cells provides
an invaluable resource for drug or toxicology screening, medical research, and patient …